( April 10, 2025, 12:20 PM EDT) -- FORT WORTH, Texas — The U.S. Food and Drug Administration properly determined that the shortage of tirzepatide, an FDA-approved drug for diabetes and weight loss, had ended when it removed the drug from the agency’s drug shortage list, and its order was consistent with the requirements of the Administrative Procedure Act (APA), the agency tells a Texas federal court in a motion for summary judgment....